Glumetinib
- Generic Name
- Glumetinib
- Drug Type
- Small Molecule
- Chemical Formula
- C21H17N9O2S
- CAS Number
- 1642581-63-2
- Unique Ingredient Identifier
- 7JTT036WGX
Overview
Glumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
Background
Glumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
Indication
用于具有间质-上皮转化因子（MET）外显子14（MET-14）跳变的局部晚期或转移性非小细胞肺癌（NSCLC）的治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath